BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10650847)

  • 1. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis.
    Münchow N; Kosch A; Schobess R; Junker R; Auberger K; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S109-12. PubMed ID: 10650847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
    Heller C; Schobess R; Kurnik K; Junker R; Günther G; Kreuz W; Nowak-Göttl U
    Br J Haematol; 2000 Nov; 111(2):534-9. PubMed ID: 11122096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.
    Nowak-Göttl U; Wermes C; Junker R; Koch HG; Schobess R; Fleischhack G; Schwabe D; Ehrenforth S
    Blood; 1999 Mar; 93(5):1595-9. PubMed ID: 10029588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.
    Kosch A; Junker R; Kurnik K; Schobess R; Günther G; Koch H; Nowak-Göttl U
    Thromb Res; 2000 Sep; 99(6):531-7. PubMed ID: 10974337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.
    Nowak-Göttl U; Sträter R; Heinecke A; Junker R; Koch HG; Schuierer G; von Eckardstein A
    Blood; 1999 Dec; 94(11):3678-82. PubMed ID: 10572079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group.
    Ehrenforth S; Junker R; Koch HG; Kreuz W; Münchow N; Scharrer I; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S97-104. PubMed ID: 10650845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors.
    Günther G; Junker R; Sträter R; Schobess R; Kurnik K; Heller C; Kosch A; Nowak-Göttl U;
    Stroke; 2000 Oct; 31(10):2437-41. PubMed ID: 11022077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines.
    Knöfler R; Siegert E; Lauterbach I; Taut-Sack H; Siegert G; Gehrisch S; Müller D; Rupprecht E; Kabus M
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S147-50. PubMed ID: 10650856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey.
    Sträter R; Vielhaber H; Kassenböhmer R; von Kries R; Göbel U; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S122-5. PubMed ID: 10650850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombotic risk factors in childhood stroke and venous thrombosis.
    Heller C; Becker S; Scharrer I; Kreuz W
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S117-21. PubMed ID: 10650849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
    Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital prothrombotic disorders in children with peripheral venous and arterial thromboses.
    Albisetti M; Moeller A; Waldvogel K; Bernet-Buettiker V; Cannizzaro V; Anagnostopoulos A; Balmer C; Schmugge M
    Acta Haematol; 2007; 117(3):149-55. PubMed ID: 17159337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.
    von Depka M; Nowak-Göttl U; Eisert R; Dieterich C; Barthels M; Scharrer I; Ganser A; Ehrenforth S
    Blood; 2000 Nov; 96(10):3364-8. PubMed ID: 11071628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study.
    Heidenreich S; Junker R; Wolters H; Lang D; Hessing S; Nitsche G; Nowak-Göttl U
    J Am Soc Nephrol; 2003 Jan; 14(1):234-9. PubMed ID: 12506156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.
    Torun YA; Patiroglu T; Ozdemir MA; Ozkul Y; Ekici A; Karakukcu M
    Clin Appl Thromb Hemost; 2012; 18(2):218-21. PubMed ID: 21873357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis.
    Larsen TB; Nørgaard-Pedersen B; Lundemose JB; Rüdiger N; Gaustadnes M; Brandslund I
    Thromb Res; 2000 May; 98(4):233-9. PubMed ID: 10822069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
    Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
    Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.